We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Merck KGAA | TG:MRK | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.60 | 0.38% | 156.55 | 156.50 | 158.05 | 157.95 | 155.00 | 156.65 | 5,931 | 20:59:29 |
From Oct 2019 to Oct 2024
Merck & Co. (MRK) Chief Executive Richard Clark says the company will publish details of its payments to doctors, amid charges that pharmaceutical companies have too much influence over doctors' prescription decisions, The Financial Times reports Wednesday. The disclosures, to start in the fourth quarter, will make Merck the largest pharmaceutical to publish such information, according to the FT. "The system needs to be totally transparent," Clark told the paper. He also questioned whether there was a need for an annual ceiling on payments.
Full story at http://www.ft.com/cms/s/0/f49fc0b0-a86c-11de-9242-00144feabdc0.html
-Dow Jones Newswires; 212-416-2900
1 Year Merck KGAA Chart |
1 Month Merck KGAA Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
